Table: Apex Biotechnology Apr Rev NT$151.0M Vs NT$187.3M

About this update from Apex Biotechnology Corp.

Apex Biotechnology Corp. - Taiwan Figures in New Taiwan dollars. 2026 2025 Revenue NT$151,037,000 NT$187,262,000 Jan-Apr Revenue NT$670,760,000 NT$746,015,000 Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to [email protected].

View stock analysis, news, and events for Apex Biotechnology Corp.